Signalling by protein phosphatases and drug development: A systems-centred view

48Citations
Citations of this article
97Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Protein modification cycles catalysed by opposing enzymes, such as kinases and phosphatases, form the backbone of signalling networks. Although, historically, kinases have been at the research forefront, a systems-centred approach reveals predominant roles for phosphatases in controlling the network response times and spatio-temporal profiles of signalling activities. Emerging evidence suggests that phosphatase kinetics are critical for network function and cell-fate decisions. Protein phosphatases operate as both immediate and delayed regulators of signal transduction, capable of attenuating or amplifying signalling. This versatility of phosphatase action emphasizes the need for systems biology approaches to understand cellular signalling networks and predict the cellular outcomes of combinatorial drug interventions. © 2012 The Authors Journal compilation © 2012 FEBS.

Cite

CITATION STYLE

APA

Nguyen, L. K., Matallanas, D., Croucher, D. R., Von Kriegsheim, A., & Kholodenko, B. N. (2013, January). Signalling by protein phosphatases and drug development: A systems-centred view. FEBS Journal. https://doi.org/10.1111/j.1742-4658.2012.08522.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free